• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在亚洲印度人群中,非酒精性脂肪性肝病在发病时可能并非严重疾病。

Non-alcoholic fatty liver disease may not be a severe disease at presentation among Asian Indians.

作者信息

Madan Kaushal, Batra Yogesh, Gupta S Datta, Chander Bal, Rajan K D Anand, Tewatia M S, Panda S K, Acharya S K

机构信息

Department of Gastroenterology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi.

出版信息

World J Gastroenterol. 2006 Jun 7;12(21):3400-5. doi: 10.3748/wjg.v12.i21.3400.

DOI:10.3748/wjg.v12.i21.3400
PMID:16733858
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4087872/
Abstract

AIM

To evaluate the clinical and biochemical profile of patients with non alcoholic fatty liver disease (NAFLD) and to assess their histological severity at presentation.

METHODS

Consecutive patients presenting to the liver clinic of All India Institute of Medical Sciences (AIIMS) with raised transaminases to at least 1.5 times upper limit of normal, and histologically confirmed non-alcoholic fatty liver disease were included. Patients who had significant alcohol intake or positive markers of other liver diseases or who were taking drugs known to produce fatty liver were excluded. The clinical, biochemical and histological profile of this group was studied.

RESULTS

Fifty-one patients with NAFLD formed the study population. Their median age and BMI were 34(17-58) years and 26.7(21.3-32.5) kg/m(2) respectively and 46 (90.1%) were males. The majority of the patients had mild inflammation, either grade 1 [32 (63%)] or grade 2 [16 (31%)] and only 3 (6%) patients had severe (grade 3) inflammation. Twenty-three (45%), 19 (37%), 8(16%) and 1(2%) patient had stage 0, 1, 2 and 3 fibrosis respectively on index biopsy and none had cirrhosis. On univariate analysis, triglyceride levels more than 150 mg % (OR = 7.1; 95% CI: 1.6-31.5, P = 0.002) and AST/ALT ratio>1 (OR = 14.3; 95% CI: 1.4-678.5, P = 0.008) were associated with high grades of inflammation and none was associated with advanced fibrosis. On multivariate logistic regression analysis, hypertriglyceridemia >150 mg% was the only factor independently associated with presence of high grade of inflammation (OR = 1.6; 95% CI: 1.3-22.7, P = 0.02), while none was associated with advanced fibrosis. Triglyceride levels correlated positively with inflammatory grade (r = 0.412; P = 0.003).

CONCLUSION

NAFLD in North Indian patients is a disease of young over-weight males, most of whom are insulin resistant and they tend to have a mild histological disease at presentation.

摘要

目的

评估非酒精性脂肪性肝病(NAFLD)患者的临床和生化特征,并在就诊时评估其组织学严重程度。

方法

纳入全印度医学科学研究所(AIIMS)肝病门诊连续就诊的转氨酶升高至至少正常上限1.5倍且经组织学证实为非酒精性脂肪性肝病的患者。排除有大量酒精摄入或其他肝病阳性标志物或正在服用已知可导致脂肪肝药物的患者。研究该组患者的临床、生化和组织学特征。

结果

51例NAFLD患者构成研究人群。他们的年龄中位数和BMI分别为34(17 - 58)岁和26.7(21.3 - 32.5)kg/m²,46例(90.1%)为男性。大多数患者有轻度炎症,1级[32例(63%)]或2级[16例(31%)],只有3例(6%)患者有重度(3级)炎症。初次活检时,23例(45%)、19例(37%)、8例(16%)和1例(2%)患者分别处于0、1、2和3期纤维化,无患者有肝硬化。单因素分析显示,甘油三酯水平超过150mg%(OR = 7.1;95%CI:1.6 - 31.5,P = 0.002)和AST/ALT比值>1(OR = 14.3;95%CI:1.4 - 678.5,P = 0.008)与高度炎症相关,且均与晚期纤维化无关。多因素逻辑回归分析显示,高甘油三酯血症>150mg%是唯一与高度炎症存在独立相关的因素(OR = 1.6;95%CI:1.3 - 22.7,P = 0.02),而均与晚期纤维化无关。甘油三酯水平与炎症分级呈正相关(r = 0.412;P = 0.003)。

结论

北印度患者的NAFLD是一种年轻超重男性的疾病,他们大多有胰岛素抵抗,就诊时组织学病变往往较轻。

相似文献

1
Non-alcoholic fatty liver disease may not be a severe disease at presentation among Asian Indians.在亚洲印度人群中,非酒精性脂肪性肝病在发病时可能并非严重疾病。
World J Gastroenterol. 2006 Jun 7;12(21):3400-5. doi: 10.3748/wjg.v12.i21.3400.
2
Correlation of adipose tissue with liver histology in Asian Indian patients with nonalcoholic fatty liver disease (NAFLD).亚洲印第安非酒精性脂肪性肝病(NAFLD)患者脂肪组织与肝组织学的相关性。
Ann Hepatol. 2012 Jul-Aug;11(4):478-86.
3
Non-alcoholic fatty liver disease is closely associated with sub-clinical inflammation: a case-control study on Asian Indians in North India.非酒精性脂肪性肝病与亚临床炎症密切相关:一项针对印度北部亚裔人群的病例对照研究。
PLoS One. 2013;8(1):e49286. doi: 10.1371/journal.pone.0049286. Epub 2013 Jan 11.
4
Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians.非酒精性脂肪性肝病与亚临床动脉粥样硬化相关,而与亚洲印第安人的肥胖和代谢综合征无关。
Atherosclerosis. 2012 Aug;223(2):507-11. doi: 10.1016/j.atherosclerosis.2012.06.005. Epub 2012 Jun 13.
5
Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Albanian overweight children.阿尔巴尼亚超重儿童的非酒精性脂肪性肝病和非酒精性脂肪性肝炎
Minerva Pediatr. 2014 Feb;66(1):23-30.
6
Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.瘦型非酒精性脂肪性肝病增加了正常体重中国人群发生代谢紊乱的风险。
World J Gastroenterol. 2014 Dec 21;20(47):17932-40. doi: 10.3748/wjg.v20.i47.17932.
7
Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.肥胖和代谢综合征作为通过超声诊断的非酒精性脂肪性肝病发生的风险因素。
Vojnosanit Pregl. 2016 Oct;73(10):910-20. doi: 10.2298/VSP150514093P.
8
Non-alcoholic fatty liver disease's prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese.非酒精性脂肪性肝病的流行情况及其对中国代谢综合征患者丙氨酸氨基转移酶的影响。
J Gastroenterol Hepatol. 2011 Apr;26(4):722-30. doi: 10.1111/j.1440-1746.2010.06509.x.
9
Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy.意大利南部严重肥胖的非糖尿病青年成人中的非酒精性脂肪性肝病
Ann Nutr Metab. 2005 Sep-Oct;49(5):289-95. doi: 10.1159/000087295. Epub 2005 Aug 2.
10
Nonalcoholic fatty liver disease across ethno-racial groups: do Asian-American adults represent a new at-risk population?非酒精性脂肪性肝病在不同种族群体中的分布:亚裔美国人是否代表了一个新的高危人群?
J Gastroenterol Hepatol. 2011 Mar;26(3):501-9. doi: 10.1111/j.1440-1746.2010.06443.x.

引用本文的文献

1
Understanding Insulin Resistance in NAFLD: A Systematic Review and Meta-Analysis Focused on HOMA-IR in South Asians.理解非酒精性脂肪性肝病中的胰岛素抵抗:一项聚焦于南亚人胰岛素抵抗指数的系统评价和荟萃分析
Cureus. 2024 Oct 3;16(10):e70768. doi: 10.7759/cureus.70768. eCollection 2024 Oct.
2
Significance of Correlation of Shear Wave Elastography With Fibrosis-4 in a Cohort of Patients With Diabetes and Nonalcoholic Fatty Liver Disease.剪切波弹性成像与纤维化-4在糖尿病和非酒精性脂肪性肝病患者队列中的相关性意义
Cureus. 2024 Aug 16;16(8):e67015. doi: 10.7759/cureus.67015. eCollection 2024 Aug.
3
A Prospective Randomised Comparative Four-arm Intervention Study of Efficacy and Safety of Saroglitazar and Vitamin E in Patients With Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH)-SVIN TRIAL.一项关于沙罗格列他与维生素E治疗非酒精性脂肪性肝病(NAFLD)/非酒精性脂肪性肝炎(NASH)疗效和安全性的前瞻性随机对照四臂干预研究——SVIN试验
J Clin Exp Hepatol. 2024 Sep-Oct;14(5):101398. doi: 10.1016/j.jceh.2024.101398. Epub 2024 Mar 18.
4
Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD).印度国家肝脏研究协会(INASL)关于非酒精性脂肪性肝病(NAFLD)命名、诊断和治疗的指导文件。
J Clin Exp Hepatol. 2023 Mar-Apr;13(2):273-302. doi: 10.1016/j.jceh.2022.11.014. Epub 2022 Dec 7.
5
Comparison of Clinical, Biochemical, and Histopathologic Profiles between NAFLD in Asian-Indians and United States Adults.亚洲印度人与美国成年人非酒精性脂肪性肝病的临床、生化和组织病理学特征比较
Euroasian J Hepatogastroenterol. 2022 Jul;12(Suppl 1):S15-S18. doi: 10.5005/jp-journals-10018-1362.
6
FibroScan-AST (FAST) Score for Nonalcoholic Steatohepatitis - Validation in an Indian Cohort.非酒精性脂肪性肝炎的FibroScan-AST(FAST)评分——在印度队列中的验证
J Clin Exp Hepatol. 2022 Mar-Apr;12(2):440-447. doi: 10.1016/j.jceh.2021.06.008. Epub 2021 Jun 15.
7
Nonalcoholic Fatty Liver Disease: Indian Perspective.非酒精性脂肪性肝病:印度视角
Clin Liver Dis (Hoboken). 2021 Sep 13;18(3):158-163. doi: 10.1002/cld.1141. eCollection 2021 Sep.
8
Primary Versus Secondary NAFLD: Perspective on Advanced Fibrosis.原发性与继发性非酒精性脂肪性肝病:关于晚期肝纤维化的观点
J Clin Exp Hepatol. 2021 Sep-Oct;11(5):557-564. doi: 10.1016/j.jceh.2020.12.009. Epub 2020 Dec 31.
9
Prevalence of fatty liver in metabolic syndrome.代谢综合征中脂肪肝的患病率。
J Family Med Prim Care. 2020 Jul 30;9(7):3246-3250. doi: 10.4103/jfmpc.jfmpc_1108_19. eCollection 2020 Jul.
10
Difference in lifestyle and metabolic profile of non-alcoholic fatty liver disease with raised alanine amino-transferases between obese and non-overweight subjects.肥胖与非超重人群中丙氨酸氨基转移酶升高的非酒精性脂肪性肝病患者生活方式和代谢特征的差异。
Sci Rep. 2020 Sep 17;10(1):15232. doi: 10.1038/s41598-020-72306-x.

本文引用的文献

1
The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies.非酒精性脂肪性肝病的组织学病程:一项对103例接受序贯肝活检患者的纵向研究
J Hepatol. 2005 Jan;42(1):132-8. doi: 10.1016/j.jhep.2004.09.012.
2
Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH.非酒精性脂肪性肝炎:肝硬化、肝细胞癌及静止期非酒精性脂肪性肝炎。
J Gastroenterol. 2004 Dec;39(12):1215-8. doi: 10.1007/s00535-004-1475-x.
3
Prevalence of sustained hypertension and obesity in urban and rural school going children in Ludhiana.卢迪亚纳城乡学童持续性高血压和肥胖症的患病率
Indian Heart J. 2004 Jul-Aug;56(4):310-4.
4
Prevalence of nonalcoholic fatty liver disease in coastal eastern India: a preliminary ultrasonographic survey.印度东部沿海地区非酒精性脂肪性肝病的患病率:一项初步超声检查调查
Trop Gastroenterol. 2004 Apr-Jun;25(2):76-9.
5
The metabolic syndrome: prevalence in worldwide populations.代谢综合征:全球人群中的患病率。
Endocrinol Metab Clin North Am. 2004 Jun;33(2):351-75, table of contents. doi: 10.1016/j.ecl.2004.03.005.
6
Assessment of insulin resistance and effect of metformin in nonalcoholic steatohepatitis--a preliminary report.
Indian J Gastroenterol. 2004 Jan-Feb;23(1):12-5.
7
Insulin resistance syndrome (metabolic syndrome) and obesity in Asian Indians: evidence and implications.亚洲印度人的胰岛素抵抗综合征(代谢综合征)与肥胖:证据及影响
Nutrition. 2004 May;20(5):482-91. doi: 10.1016/j.nut.2004.01.020.
8
Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies.亚洲人群的适宜体重指数及其对政策和干预策略的影响。
Lancet. 2004 Jan 10;363(9403):157-63. doi: 10.1016/S0140-6736(03)15268-3.
9
The prevalence and etiology of elevated aminotransferase levels in the United States.美国转氨酶水平升高的患病率及病因
Am J Gastroenterol. 2003 May;98(5):960-7. doi: 10.1111/j.1572-0241.2003.07486.x.
10
Correlations of C-reactive protein levels with anthropometric profile, percentage of body fat and lipids in healthy adolescents and young adults in urban North India.印度北部城市健康青少年和青年中C反应蛋白水平与人体测量指标、体脂百分比及血脂的相关性
Atherosclerosis. 2003 Jun;168(2):305-13. doi: 10.1016/s0021-9150(03)00096-0.